We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: FTSE left behind as CAC and DAX hit records

Thu, 18th Nov 2021 12:10

(Alliance News) - While European bourses were busy clocking record highs on Thursday, the FTSE 100 continued to trundle behind, hampered by a stronger pound and weaker oil price.

While sterling strength was bad news for London's blue-chip index, it acted as a boon for the more domestically-focused FTSE 250, which was trading nearly 90 points higher at midday.

The FTSE 100 index was down 12.51 points, or 0.2%, at 7,278.69 midday Thursday. The FTSE 250 index was up 87.39 points, or 0.4%, at 23,521.46. The AIM All-Share index was down 5.67 points, or 0.5%, at 1,241.21.

The Cboe UK 100 index was down 0.2% at 721.14. The Cboe 250 was up 0.3% at 20,977.40 and the Cboe Small Companies down 0.6% at 15,495.35.

In mainland Europe, the CAC 40 in Paris was up 0.2%, while the DAX 40 in Frankfurt was up 0.1%. Both hit fresh record highs in morning trade Thursday.

In contrast to its European counterparts, the FTSE 100 has so far been unable to break above pre-pandemic levels and remains well below its record high of 7,903.50 set back in 2018.

Capping any progress for the blue-chip index this week has been a resurgent pound, regaining some momentum after a tumble earlier in the month when the Bank of England surprised markets with a decision to hold interest rates.

However, stronger-than-expected UK inflation and jobs data this week has set the stage for a December rate hike.

Sterling was quoted at USD1.3499 midday Thursday, higher than USD1.3465 at the London equities close on Wednesday and up around 0.8% higher since the week began. The currency had topped USD1.35 before slipping back.

"When some 70% of its constituents' earnings are derived from overseas, strength in sterling isn't that helpful," commented AJ Bell investment director Russ Mould.

While higher on the day, both the euro and yen are tracking week-to-date losses. The euro traded at USD1.1344 Thursday midday, up on USD1.1309 late Wednesday. Against the yen, the dollar was quoted at JPY114.13, down from JPY114.51.

Gold was quoted at USD1,862.97 an ounce on Thursday, soft on USD1,864.44 on Wednesday.

Wall Street is set for a higher start, with the Dow Jones pointed up 0.2%, the S&P 500 up 0.3% and the Nasdaq Composite up 0.5%.

The economic events calendar on Thursday has the latest US jobless claims numbers at 1330 GMT.

In London, energy majors were weighing on the FTSE 100 as oil prices retreated. Brent oil was trading at USD79.98 a barrel, falling from USD81.58 late Wednesday.

Crude prices received a knock after US President Joe Biden called on US regulators Wednesday to look into the causes of the nationwide spike in gasoline prices, which he said is hurting workers. In a letter to the Federal Trade Commission, Biden took aim at oil companies he says are raising prices at the pump even as their expenses decline and profits soar.

Royal Dutch Shell 'A' and 'B' shares were both down 1.9% at midday, while BP fell 1.6%.

The worst performer in the index was GlaxoSmithKline, falling 2.6% as the stock went ex-dividend, meaning new buyers no longer qualify for the latest payout.

Topping the index was Royal Mail, the postal operator up 5.7% as investors gave plans for GBP400 million worth of shareholder returns their stamp of approval.

Revenue in the first half ended September 26 climbed 7.1% year-on-year to GBP6.07 billion from GBP5.67 billion. Royal Mail's pretax profit multiplied to GBP315 million from GBP17 million a year earlier.

Royal Mail declared an interim dividend of 6.7 pence, having paid none last year. It also will pay a special dividend worth GBP200 million in total and also will start a GBP200 million share buyback immediately.

The more domestically-focused FTSE 250 was outperforming on Thursday, helped as Playtech shares rose 4.4% on a potential third suitor.

The gambling software provider confirmed that on November 5, it received a preliminary approach from JKO Play. JKO is controlled by Eddie Jordan and Keith O'Loughlin. This third approach follows Gopher Investments making an approach for the company - just days after Playtech accepted a GBP2.1 billion offer from Aristocrat Leisure, which closed down 3.6% in Sydney on Thursday.

Shares in Mecca Bingo owner Rank Group rose 3.2% in a positive read-across after blue-chip Flutter Entertainment agreed to buy online bingo operator Tombola for GBP402 million.

Limiting the FTSE 250's advance was a 15% slump in Biffa shares. The waste management firm reinstated its interim dividend after a first half that saw revenue top levels seen prior to the coronavirus pandemic, but it warned that progress at its Seaham recycling plant has been slower than expected.

The High Wycombe, England-based company trimmed its pretax loss to GBP25.6 million for the first half ended September 24 from GBP52.5 million a year previously.

Rotork fell 7.4% on a warning over supply chain strife. Bath-based Rotork, which serves the energy, water and chemical industries, said order intake has remained strong, but supply chain disruption is set to continue at least in the near-term.

Rotork said component sourcing over the past few months has become difficult, resulting in revenue over the four-month period being down year-on-year and hitting margins.

Elsewhere in London, Metro Bank shares dived 18% after agreeing to end talks over a possible takeover offer by private equity firm Carlyle Group for the retail bank. Both parties announced the decision but neither gave a reason.

"The board continues to strongly believe in the standalone strategy and future prospects of Metro Bank," the lender said.

However, Interactive Investor's Victoria Scholar believes a standalone future for the bank could be short-lived. "With interest rates in the UK on the cusp of moving higher and with Metro Bank's share price down more than 20% year-to-date, the challenger lender remains a possible M&A target," she said.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.